Calculating l Safe Start t Doses from Toxicology Studies

28.08.2015 • Views

Share Embed Flag

Calculating l Safe Start t Doses from Toxicology Studies

Calculating clinical start dose from toxicology studies - The Israel ...

DOWNLOAD ePAPER

pdaisrael.co.il

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

Thank you for your attention!<br />

Food and Drug Administration

Previous page
Next page

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

Safety Qualification of Impurities in Biopharmaceutical Drugs

Regulation of Impurities in Drug Substances and Products Risk Assessment

Regulation of impurities in drug substances and products

ICH Q11 Presentation by Alex Weisman - The Israel Chapter of PDA

Thank you for your attention! Food and Drug Administration

Page 1 and 2: Calculating l Safe Start t Doses fr
Page 3 and 4: CDER guidance on “start dose”
Page 5 and 6: Safety Factor ‣ Application of sa
Page 7 and 8: Changes in start t dose ‣ It is a
Page 9 and 10: Food and Drug Administration
Page 11 and 12: Events in clinical trial ‣ TeGene
Page 13 and 14: CD28 Monoclonal Trial in UK ‣ No
Page 15 and 16: Could this toxicity have been predi
Page 17 and 18: Other clues ‣ OKT3, murine monocl
Page 19 and 20: Reaction to Tegenero Incident ‣ E
Page 21 and 22: MABEL Approach ‣ “Minimal Antic
Page 23: EMEA Guidance ‣ On its face, this